Associate Professor of Psychiatry
Board-certified addiction and general psychiatrist who has spent over a decade researching novel treatments for substance use disorders. He is a principal investigator on several NIH-funded grants evaluating ketamine combined with behavioral therapies for treating cocaine, opioid, and alcohol use disorders.